Link Technologies showcases Link Plus range at OTS 2013

Link Technologies has announced the launch of its high-end Link Plus product range at the 2013 annual meeting of the Oligonucleotide Therapeutic Society (OTS) in Naples.

The Link Plus portfolio is a collection of premium phosphoramidites manufactured to the highest available industry standard, bringing unprecedented levels of quality to the modifier reagent market.

Customers will also benefit from a bespoke service from order to delivery, which includes a detailed impurity profile for thorough quality assurance, as well as support and managed supply throughout the entirety of project life cycles.

The Link Plus service has been developed to offer flexibility, guaranteeing an enhanced and tailor-made customer experience.

Dr Catherine McKeen, technical manager at Link Technologies, said: "Working with several key clients has helped us develop this service and indeed some already benefit from our manufacture of tailored, highly specified products. We are now rolling this out under the Link Plus brand."

The firm gave a presentation on new potential oligonucleotide delivery reagents at the OTS event, with Dr McKeen providing relevant information and answering questions from attendees.